MercachemSyncom closes the acquisition of Admescope

 Nijmegen (the Netherlands) - 9th November 2020

MercachemSyncom, the leading mid-sized European drug-discovery contract research organization, today announced that it has acquired Admescope Ltd. based in Oulu, Finland and Södertälje, Sweden. With this acquisition, we add premium ADME-Tox to our drug discovery and development service offerings.

Scroll to top